FTRE earnings: next report 2026-07-29, real EPS beat/miss history, analyst consensus Hold, P/E -3.75. Updated 2026-07-23.
Fortrea Holdings (FTRE) Research Hub
Fortrea Holdings (FTRE) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 17.2 USD (+2.44%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -3.75, market cap 1.71B. This hub links to the full technical, earnings and options research available for FTRE.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 17.2 USD (+2.44%) |
| 52-week range | 15.2 USD – 21.39 USD |
| Trend regime | Range |
| 14-day RSI | 42.5 (Bearish) |
| Trailing P/E | -3.75 |
| Market cap | 1.71B |
| Dividend yield | 0.00% |
| Next earnings | 2026-07-29 |
Available research for FTRE
Covered Call on FTRE: how it works, illustrative setup around the real 17.2 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on FTRE: how it works, illustrative setup around the real 17.2 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on FTRE: how it works, illustrative setup around the real 17.2 USD price, max profit/loss, breakeven and when to use it. Educational.
FTRE technical analysis: range, last 17.2 USD, RSI 42.5, 52w range 15.2 USD–21.39 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is FTRE in?
Fortrea Holdings (FTRE) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is FTRE in an uptrend or downtrend?
As of 2026-09-11, FTRE is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is FTRE's trailing P/E ratio?
FTRE's trailing P/E is -3.75, with a market cap of 1.71B. See the earnings research page for full valuation detail.
When does FTRE next report earnings?
FTRE is next scheduled to report earnings on 2026-07-29, with a consensus EPS estimate of 0.18 USD.